German Biotech BioNTech Locks in $270M Series A Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace You Might Also Like Acadia Reports First Quarter 2017 Financial Results May 9, 2017 Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017 After FDA Rejection, Bay Area's Coherus Axes 30% of Employees June 27, 2017
Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017